Indivumed Inc. to Study the Integrity of Biospecimen Sampling Procedures for the U.S. National Cancer Institute

Indivumed -- Hamburg, Germany — Hamburg-based Indivumed GmbH has been awarded a subcontract by SAIC-Frederick, Inc., under its prime contract with the U.S. National Cancer Institute (NCI) to assess the impact of sampling procedures on the integrity of cancer biospecimens and key data derived from them.

MORE ON THIS TOPIC